George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMorgan Sindall Group Regulatory News (MGNS)

Share Price Information for Morgan Sindall Group (MGNS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2,265.00
Bid: 2,255.00
Ask: 2,270.00
Change: 10.00 (0.44%)
Spread: 15.00 (0.665%)
Open: 2,255.00
High: 2,290.00
Low: 2,240.00
Prev. Close: 2,255.00
MGNS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Change

14 Aug 2018 07:00

RNS Number : 6648X
Morgan Sindall Group PLC
14 August 2018
 
Morgan Sindall Group plc

 

14 August 2018

 

Morgan Sindall appoints David Lowden as a non-executive director

 

Morgan Sindall Group plc is pleased to announce the appointment of David Lowden as a non-executive director, with effect from 10 September 2018. David will be a member of the remuneration, nomination and audit committees.

 

David is a highly experienced Non-executive Director, Senior Independent Director and Chairman of UK listed companies. David is currently chair of the Board of FTSE 250 PageGroup having previously chaired the Remuneration Committee for three years. He is also chair of the audit & risk committee at William Hill and recently stepped down as SID from the Board of Berendsen. David was formerly Chief Executive of Taylor Nelson Sofres plc, having initially joined as Group Finance Director in 1999. David has spent his career working for a number of companies in senior finance roles, including as Group Finance Director at Asprey plc prior to joining Taylor Nelson Sofres. As a CFO as well as CEO, he has supported growth and profitability through the efficient design of business operations and appropriate use of systems and processes.

 

Commenting on the appointment, Michael Findlay, chairman of Morgan Sindall Group plc, said:

 

"We are delighted to welcome David to the Board. His extensive experience as both an executive and non-executive director of various successful companies will bring valuable knowledge and insight to Board discussions. I look forward to working with David in the coming years."

 

Ends

Notes to Editors:

There are no other details requiring disclosure under Listing Rule 9.6.13 in relation to David Lowden.

 

Morgan Sindall Group plc is a leading UK construction and regeneration group with revenue of c£2.8 billion and which operates through six divisions of Construction & Infrastructure, Fit Out, Property Services, Partnership Housing, Urban Regeneration and Investments.

 

ENQUIRIES:

Morgan Sindall Group plc

Tel: 07816 958187

Michael Findlay, Chair

Instinctif Partners (Financial PR)

Tel: 020 7457 2020

MorganSindall@instinctif.com

 

Matthew Smallwood

 

Tel: 07831 379 122

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BOABLGDICGBBGIX
Date   Source Headline
20th Apr 202310:24 amRNSBlock listing Interim Review
23rd Mar 20231:51 pmRNSAnnual Financial Report
21st Mar 20234:24 pmRNSAdditional Listing
16th Mar 20233:34 pmRNSDirector/PDMR Shareholding
16th Mar 20231:52 pmRNSDirector/PDMR Shareholding
14th Mar 20237:00 amRNSUK Government Self Remediation Contract
13th Mar 20232:40 pmRNSDirector/PDMR Shareholding
3rd Mar 202311:58 amRNSDirector/PDMR Shareholding
3rd Mar 202311:57 amRNSDirector/PDMR Shareholding
2nd Mar 20234:42 pmRNSDirector/PDMR Shareholding
2nd Mar 20234:41 pmRNSDirector/PDMR Shareholding
1st Mar 202311:28 amRNSTotal Voting Rights
23rd Feb 20237:00 amRNSFinal Results
6th Feb 20237:00 amRNSNotice of Full Year Results
1st Feb 20231:04 pmRNSTotal Voting Rights
25th Jan 20232:59 pmRNSHolding(s) in Company
3rd Jan 20231:56 pmRNSTotal Voting Rights
12th Dec 20228:25 amRNSHolding(s) in Company
5th Dec 20223:37 pmRNSHolding(s) in Company
2nd Dec 20229:06 amRNSTotal Voting Rights
7th Nov 20224:08 pmRNSAGM Voting Update
2nd Nov 20227:00 amRNSTrading Update
1st Nov 20221:49 pmRNSTotal Voting Rights
20th Oct 202211:00 amRNSBlock listing Interim Review
18th Oct 20221:16 pmRNSAdditional Listing
3rd Oct 20221:51 pmRNSTotal Voting Rights
13th Sep 20223:27 pmRNSAdditional Listing
1st Sep 202210:43 amRNSTotal Voting Rights
19th Aug 202211:00 amRNSDirector/PDMR Shareholding
4th Aug 20227:00 amRNSHalf-year Report
1st Aug 202210:16 amRNSTotal Voting Rights
11th Jul 20227:00 amRNSNotice of Results
1st Jul 202210:50 amRNSTotal Voting Rights
14th Jun 202212:51 pmRNSAdditional Listing
6th Jun 202212:00 pmRNSTotal Voting Rights
1st Jun 20223:49 pmRNSDirector Declaration
17th May 20221:47 pmRNSHolding(s) in Company
10th May 202211:23 amRNSAdditional Listing
5th May 20224:45 pmRNSResult of AGM
5th May 20227:00 amRNSAGM Trading Update
3rd May 20223:48 pmRNSTotal Voting Rights
20th Apr 202210:25 amRNSBlock listing Interim Review
5th Apr 202210:40 amRNSAdditional Listing
5th Apr 20227:00 amRNSMeet the Management Forum
1st Apr 202210:36 amRNSTotal Voting Rights
24th Mar 202212:46 pmRNSAnnual Financial Report
18th Mar 202211:57 amRNSDirector/PDMR Shareholding
16th Mar 20223:03 pmRNSDirector/PDMR Shareholding
16th Mar 20229:23 amRNSDirector/PDMR Shareholding
16th Mar 20229:21 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.